Stock Analysis on Net
Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

Adjustments to Financial Statements

Microsoft Excel

Adjustments to Current Assets

Medtronic PLC, adjusted current assets

US$ in millions

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
As Reported
Current assets 24,787 23,814 21,935 21,675 23,059 22,548
Adjustments
Add: Allowances and credit losses 190 199 173 176 230 241
After Adjustment
Adjusted current assets 24,977 24,013 22,108 21,851 23,289 22,789

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The financial trajectory of current assets and their adjusted counterparts exhibits a period of volatility followed by a sustained growth phase. Between 2021 and 2023, assets experienced an initial increase followed by a contraction, after which a consistent upward trend is observed through 2026.

Current Asset Performance
Current assets rose from US$ 22,548 million in 2021 to US$ 23,059 million in 2022, before declining to a period low of US$ 21,675 million in 2023. A recovery began in 2024, with values climbing to US$ 24,787 million by 2026, representing an overall increase in liquidity levels over the six-year horizon.
Adjusted Current Asset Trends
Adjusted current assets mirrored the movements of the reported current assets, starting at US$ 22,789 million in 2021 and reaching US$ 24,977 million by 2026. The adjusted figures remained consistently higher than the reported current assets across every reporting period, indicating a persistent positive adjustment to the asset base.
Analysis of Adjustment Variance
The variance between current assets and adjusted current assets remained relatively stable, fluctuating between a maximum of US$ 241 million in 2021 and a minimum of US$ 173 million in 2024. This delta suggests a systematic adjustment process where the impact of the adjustment is minor relative to the total asset volume, yet consistent in its application.

AI Ask an analyst for more



Adjustments to Total Assets

Medtronic PLC, adjusted total assets

US$ in millions

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
As Reported
Total assets 93,028 91,680 89,981 90,948 90,981 93,083
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
Add: Allowances and credit losses 190 199 173 176 230 241
Less: Deferred tax assets2 3,737 3,907 3,561 3,388 3,336 3,114
After Adjustment
Adjusted total assets 89,481 87,972 86,593 87,736 87,875 90,210

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

2 Deferred tax assets. See details »


The financial trajectory of total assets and adjusted total assets exhibits a consistent U-shaped pattern over the analyzed six-year period. Both metrics experienced a steady decline from April 2021 through April 2024, followed by a recovery phase that returned asset levels to near-initial figures by April 2026.

Total Asset Trends
Total assets decreased from 93,083 million US$ in 2021 to a low of 89,981 million US$ in 2024. A reversal occurred in 2025, with values rising to 91,680 million US$, and continuing upward to 93,028 million US$ by April 2026, effectively neutralizing the losses sustained during the preceding three years.
Adjusted Total Asset Trajectory
Adjusted total assets mirrored the movement of total assets, starting at 90,210 million US$ in 2021 and descending to a minimum of 86,593 million US$ in 2024. A subsequent recovery led to a value of 89,481 million US$ by April 2026.
Adjustment Variance Analysis
The gap between total assets and adjusted total assets widened progressively from 2021 to 2025. The absolute difference grew from 2,873 million US$ in 2021 to a peak of 3,708 million US$ in 2025, before slightly contracting to 3,547 million US$ in 2026. This trend indicates that the assets subject to adjustment represented an increasing proportion of the overall asset base during the period of contraction and the initial phase of recovery.

AI Ask an analyst for more



Adjustments to Current Liabilities

Medtronic PLC, adjusted current liabilities

US$ in millions

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
As Reported
Current liabilities 11,658 12,879 10,789 9,051 12,394 8,509
Adjustments
Less: Deferred revenue (included in Other accrued expenses) 405 354 352 314 305 276
After Adjustment
Adjusted current liabilities 11,253 12,525 10,437 8,737 12,089 8,233

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


An analysis of the current liabilities from April 2021 through April 2026 reveals a pattern of volatility characterized by significant fluctuations in short-term obligations. The total current liabilities exhibit a non-linear trend, with peak values occurring in April 2022 and April 2025, interspersed with periods of contraction.

Trend Analysis of Current Liabilities
Current liabilities experienced a sharp increase of approximately 45.7% between April 2021 and April 2022, rising from 8,509 million to 12,394 million. This was followed by a substantial correction in April 2023, where obligations fell to 9,051 million. A subsequent upward trajectory is observed leading into April 2025, reaching a period high of 12,879 million, before a projected decline to 11,658 million by April 2026.
Behavior of Adjusted Current Liabilities
The adjusted current liabilities closely mirror the movement of the standard current liabilities, maintaining a consistent correlation throughout the observed period. The adjusted figures likewise peak in April 2022 and April 2025, suggesting that the adjustments applied do not fundamentally alter the overall trajectory of the company's short-term liability profile.
Variance Analysis of Adjustments
A persistent gap exists between the reported current liabilities and the adjusted current liabilities. This variance has demonstrated a steady incremental increase over time. The difference was 276 million in April 2021 and grew progressively each year, reaching 352 million in April 2024 and expanding further to 405 million by April 2026. The gradual expansion of this adjustment suggests a systematic increase in the specific items being excluded or modified to arrive at the adjusted figure.

The data indicates that while the total volume of short-term liabilities is subject to periodic volatility, the adjustment applied to these liabilities is growing in absolute terms, representing an increasing divergence between the statutory and adjusted reporting of current obligations.

AI Ask an analyst for more



Adjustments to Total Liabilities

Medtronic PLC, adjusted total liabilities

US$ in millions

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
As Reported
Total liabilities 42,956 43,424 39,561 39,283 38,260 41,481
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1
Less: Deferred tax liabilities2 362 403 515 708 884 1,028
Less: Deferred revenue 500 446 453 405 399 368
Less: Restructuring reserve 175 150 147 230 110 146
After Adjustment
Adjusted total liabilities 41,919 42,425 38,446 37,940 36,867 39,939

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Deferred tax liabilities. See details »


An analysis of total and adjusted liabilities reveals a consistent correlation in their fluctuations over the six-year period. Both metrics experienced an initial contraction between April 2021 and April 2022, succeeded by a period of sustained growth that culminated in April 2025, followed by a slight downturn by April 2026.

Liability Trajectory and Volatility
Total liabilities decreased from 41,481 million USD in 2021 to 38,260 million USD in 2022. Following this decline, a steady upward trend was observed over the next three years, reaching a peak of 43,424 million USD in April 2025 before receding to 42,956 million USD in April 2026. Adjusted total liabilities mirrored this movement, falling from 39,939 million USD in 2021 to 36,867 million USD in 2022, and peaking at 42,425 million USD in 2025.
Adjustment Variance Analysis
A persistent gap exists between total liabilities and adjusted total liabilities throughout the period, indicating the presence of normalizing items. The magnitude of this adjustment has shown a general downward trend. The variance was most pronounced in April 2021 at 1,542 million USD and narrowed to 1,037 million USD by April 2026. This contraction in the adjustment gap suggests a gradual reduction in the specific liabilities being excluded from the adjusted figures relative to the total balance.

AI Ask an analyst for more



Adjustments to Stockholders’ Equity

Medtronic PLC, adjusted shareholders’ equity

US$ in millions

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
As Reported
Shareholders’ equity 49,463 48,024 50,214 51,483 52,551 51,428
Adjustments
Less: Net deferred tax assets (liabilities)1 3,376 3,504 3,046 2,680 2,452 2,086
Add: Allowances and credit losses 190 199 173 176 230 241
Add: Deferred revenue 500 446 453 405 399 368
Add: Restructuring reserve 175 150 147 230 110 146
Add: Noncontrolling interests 609 232 206 182 171 174
After Adjustment
Adjusted total equity 47,561 45,547 48,147 49,796 51,009 50,271

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 Net deferred tax assets (liabilities). See details »


Shareholders' equity and adjusted total equity exhibit a synchronized trajectory over the analyzed period, characterized by a peak in 2022, a sustained decline through 2025, and a subsequent recovery in 2026.

Shareholders' Equity Trend
The equity base reached its highest valuation of 52,551 million USD in April 2022. Following this peak, a downward trend was observed for three consecutive years, with values descending to 51,483 million USD in 2023, 50,214 million USD in 2024, and reaching a period low of 48,024 million USD in April 2025. A reversal of this trend occurred in April 2026, with equity increasing to 49,463 million USD.
Adjusted Total Equity Trend
Adjusted total equity closely mirrored the movements of the reported shareholders' equity. It peaked at 51,009 million USD in April 2022 and declined steadily to a low of 45,547 million USD by April 2025. Similar to the primary equity metric, a recovery was noted in April 2026, with the value rising to 47,561 million USD.
Analysis of Equity Adjustments
A consistent negative variance is observed between shareholders' equity and adjusted total equity throughout the entire period. The magnitude of this adjustment expanded progressively from 1,157 million USD in 2021 to a maximum of 2,477 million USD in 2025. In 2026, the variance narrowed to 1,902 million USD, suggesting a reduction in the adjustments applied to the total equity figure relative to previous years.

AI Ask an analyst for more



Adjustments to Capitalization Table

Medtronic PLC, adjusted capitalization table

US$ in millions

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
As Reported
Current debt obligations 1,788 2,874 1,092 20 3,742 11
Long-term debt 26,173 25,642 23,932 24,344 20,372 26,378
Total reported debt 27,961 28,516 25,024 24,364 24,114 26,389
Shareholders’ equity 49,463 48,024 50,214 51,483 52,551 51,428
Total reported capital 77,424 76,540 75,238 75,847 76,665 77,817
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1
Add: Operating lease current liability (classified in Other accrued expenses)2 198 192 183 180 167 186
Add: Operating lease non-current liability (classified in Other liabilities)3 989 918 840 869 703 829
Adjusted total debt 29,148 29,626 26,047 25,413 24,984 27,404
Adjustments to Equity
Less: Net deferred tax assets (liabilities)4 3,376 3,504 3,046 2,680 2,452 2,086
Add: Allowances and credit losses 190 199 173 176 230 241
Add: Deferred revenue 500 446 453 405 399 368
Add: Restructuring reserve 175 150 147 230 110 146
Add: Noncontrolling interests 609 232 206 182 171 174
Adjusted total equity 47,561 45,547 48,147 49,796 51,009 50,271
After Adjustment
Adjusted total capital 76,709 75,173 74,194 75,209 75,993 77,675

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Operating lease current liability (classified in Other accrued expenses). See details »

3 Operating lease non-current liability (classified in Other liabilities). See details »

4 Net deferred tax assets (liabilities). See details »


The capitalization structure demonstrates a period of relative stability in total capital, although internal shifts between debt and equity components are evident from 2021 through 2026. A general trend of increasing leverage and declining equity is observable through the 2025 period, followed by a slight corrective shift in 2026.

Debt Trajectory and Adjustments
A consistent variance exists between reported and adjusted debt, with adjusted figures remaining higher across all periods. Reported debt decreased from US$ 26,389 million in 2021 to US$ 24,114 million in 2022, followed by a steady increase to a peak of US$ 28,516 million in 2025. The adjusted debt mirrors this trend, peaking at US$ 29,626 million in 2025, indicating a systemic adjustment that consistently increases the recognized debt load.
Equity Trends and Valuation Adjustments
Shareholders' equity exhibits a gradual downward trend, declining from US$ 51,428 million in 2021 to a low of US$ 48,024 million in 2025, before recovering slightly to US$ 49,463 million in 2026. Adjusted equity remains lower than reported equity in every period, reaching its lowest point of US$ 45,547 million in 2025. This indicates a persistent downward adjustment to the equity base throughout the analyzed timeframe.
Aggregate Capitalization Analysis
Total reported capital fluctuated within a narrow range, starting at US$ 77,817 million in 2021 and ending at US$ 77,424 million in 2026. Adjusted total capital remained consistently lower than reported figures, reflecting the net impact of the debt and equity adjustments. The stability of the adjusted total capital, which ranges from a high of US$ 77,675 million in 2021 to a low of US$ 74,194 million in 2024, suggests that the adjustments to debt and equity largely offset one another in the aggregate capitalization sum.

AI Ask an analyst for more



Adjustments to Revenues

Medtronic PLC, adjusted net sales

US$ in millions

Microsoft Excel
12 months ended: Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
As Reported
Net sales 36,364 33,537 32,364 31,227 31,686 30,117
Adjustment
Add: Increase (decrease) in deferred revenue 54 (7) 48 6 31 65
After Adjustment
Adjusted net sales 36,418 33,530 32,412 31,233 31,717 30,182

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


An analysis of revenue figures from April 2021 through April 2026 reveals a consistent long-term growth trajectory in both net sales and adjusted net sales, despite a brief period of volatility. Total net sales increased from 30,117 million USD in 2021 to 36,364 million USD by 2026, representing an overall growth of approximately 20.7% over the observed period.

Revenue Growth Patterns
A steady upward trend is observed, interrupted only by a slight contraction between April 2022 and April 2023, where net sales declined from 31,686 million USD to 31,227 million USD. Following this dip, revenue accelerated, culminating in the most significant annual increase between 2025 and 2026, with net sales rising by approximately 8.4%.
Comparative Analysis of Adjustments
The variance between net sales and adjusted net sales remains minimal across the entire reporting period. The adjustments typically represent a fraction of a percentage of total revenue, indicating that non-standard adjustments to sales figures do not materially impact the overarching financial performance profile. For instance, in 2026, the difference between net sales (36,364 million USD) and adjusted net sales (36,418 million USD) is 54 million USD, or approximately 0.15%.
Correlation of Financial Metrics
A near-perfect positive correlation exists between reported net sales and adjusted net sales. Both metrics mirrored the same peaks and troughs, specifically the 2023 contraction and the subsequent recovery. This alignment suggests that the factors driving the adjustments are independent of the primary drivers of revenue growth.

AI Ask an analyst for more



Adjustments to Reported Income

Medtronic PLC, adjusted net income attributable to Medtronic

US$ in millions

Microsoft Excel
12 months ended: Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
As Reported
Net income attributable to Medtronic 4,801 4,662 3,676 3,758 5,039 3,606
Adjustments
Add: Deferred income tax expense (benefit)1 31 (339) (528) (253) (611) (461)
Add: Increase (decrease) in allowances and credit losses (9) 26 (3) (54) (11) 33
Add: Increase (decrease) in deferred revenue 54 (7) 48 6 31 65
Add: Increase (decrease) in restructuring reserve 25 3 (83) 120 (36) 34
Add: Other comprehensive income (loss), net of tax 181 (963) 178 (1,234) 1,213 83
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest 34 32 27 26 17 32
After Adjustment
Adjusted net income 5,117 3,414 3,315 2,369 5,642 3,392

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 Deferred income tax expense (benefit). See details »


The financial trajectory from April 2021 through April 2026 is characterized by significant volatility in both reported and adjusted net income, marked by a pronounced peak in 2022 and a subsequent contraction in 2023 before entering a recovery phase.

Net Income Trends
Reported net income attributable to the company increased from 3,606 million US$ in 2021 to a peak of 5,039 million US$ in 2022. A decline followed, with figures dropping to 3,758 million US$ in 2023 and 3,676 million US$ in 2024. A consistent recovery trend is observed in the final two years, with income rising to 4,662 million US$ in 2025 and 4,801 million US$ in 2026.
Adjusted Net Income Trends
Adjusted net income exhibits more extreme fluctuations than reported net income. Following a peak of 5,642 million US$ in 2022, a sharp decline occurred in 2023, reaching a period low of 2,369 million US$. A moderate recovery was noted in 2024 and 2025, with values of 3,315 million US$ and 3,414 million US$ respectively, followed by a substantial increase to 5,117 million US$ in 2026.
Analysis of Adjustments
The variance between reported and adjusted net income indicates the impact of non-recurring items. In 2022 and 2026, adjusted net income exceeded reported net income, suggesting the exclusion of significant one-time expenses. Conversely, a notable divergence is observed in 2023, where adjusted net income was substantially lower than reported net income, indicating the removal of non-operational gains or the application of significant negative adjustments. Between 2024 and 2025, adjusted net income remained consistently below reported levels, reflecting a period of sustained negative adjustments to the reported earnings.

AI Ask an analyst for more